{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:20:34Z","timestamp":1792624834786,"version":"4.5.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,23]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Peptidyl (protein) arginine deiminases (PADs) provide the transformation of peptidyl arginine to peptidyl citrulline in the presence of calcium with posttranslational modification. The dysregulated PAD activity plays an important role on too many diseases including also the cancer. In this study, it has been aimed to determine the potential cytotoxic and apoptotic activity of chlorine-amidine (Cl-amidine) which is a PAD inhibitor and whose effectiveness has been shown in vitro and in vivo studies recently on human glioblastoma cell line Uppsala 87 malignant glioma (U-87 MG) forming an in vitro model for the glioblastoma multiforme (GBM) which is the most aggressive and has the highest mortality among the brain tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In the study, the antiproliferative and apoptotic effects of Cl-amidine on GBM cancer model were investigated. The antiproliferative effects of Cl-amidine on U-87 MG cells were determined by 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate method at the 24th and 48th hours. The apoptotic effects were analyzed by Annexin V and Propidium iodide staining, caspase-3 activation, and mitochondrial membrane polarization (5,5\u2019, 6,6\u2019-tetrachloro-1,1\u2019, 3,3\u2019 tetraethyl benzimidazolyl carbocyanine iodide) methods in the flow cytometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>It has been determined that Cl-amidine exhibits notable antiproliferative properties on U-87 MG cell line in a time and concentration-dependent manner, as determined through the 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate assay. Assessment of apoptotic effects via Annexin V and Propidium iodide staining and 5,5\u2019, 6,6\u2019-tetrachloro-1,1\u2019, 3,3\u2019 tetraethyl benzimidazolyl carbocyanine iodide methods has revealed significant efficacy, particularly following a 24-hour exposure period. It has been observed that Cl-amidine induces apoptosis in cells by enhancing mitochondrial depolarization, independently of caspase-3 activation. Furthermore, regarding its impact on healthy cells, it has been demonstrated that Cl-amidine shows lower cytotoxic effects when compared to carmustine, an important therapeutic agent for glioblastoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The findings of this study have shown that Cl-amidine exhibits significant potential as an anticancer agent in the treatment of GBM. This conclusion is based on its noteworthy antiproliferative and apoptotic effects observed in U-87 MG cells, as well as its reduced cytotoxicity toward healthy cells in comparison to existing treatments. We propose that the antineoplastic properties of Cl-amidine should be further investigated through a broader spectrum of cancer cell types. Moreover, we believe that investigating the synergistic interactions of Cl-amidine with single or combination therapies holds promise for the discovery of novel anticancer agents.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037015","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T21:04:22Z","timestamp":1708722262000},"page":"e37015","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4154-4675","authenticated-orcid":false,"given":"Pinar Naile","family":"\u00d6\u011f\u00fcten","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Department of Histology, Samsun University, Samsun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Eng\u00fcr \u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Tavas Vocational School of Health Services, Pamukkale University, Denizli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri\u015f","family":"Dikmen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, Anadolu University, Eski\u015fehir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","article-title":"Epidemiology and etiology of gliomas.","volume":"109","author":"Ohgaki","year":"2005","journal-title":"Acta Neuropathol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology, and paths to treatment.","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1634\/theoncologist.4-3-209","article-title":"New treatment strategies for malignant gliomas.","volume":"4","author":"Avgeropoulos","year":"1999","journal-title":"Oncologist"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","article-title":"Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"R5-20250503","first-page":"616","article-title":"Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential.","volume":"12","author":"Jones","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2407-9-40","article-title":"Increased PADI4 expression in blood and tissues of patients with malignant tumors.","volume":"9","author":"Chang","year":"2009","journal-title":"BMC Cancer"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease.","volume":"25","author":"Vossenaar","year":"2003","journal-title":"Bioessays"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mc.20169","article-title":"Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.","volume":"45","author":"Chang","year":"2006","journal-title":"Mol Carcinog"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1021\/bi061180d","article-title":"Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.","volume":"45","author":"Luo","year":"2006","journal-title":"Biochemistry"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11064-006-9144-5","article-title":"The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis.","volume":"32","author":"Moscarello","year":"2007","journal-title":"Neurochem Res"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jnr.20431","article-title":"Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer\u2019s disease.","volume":"80","author":"Ishigami","year":"2005","journal-title":"J Neurosci Res"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clim.2007.09.001","article-title":"Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population.","volume":"126","author":"Chen","year":"2008","journal-title":"Clin Immunol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00435.2010","article-title":"Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.","volume":"300","author":"Chumanevich","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/ml300288d","article-title":"D-amino acid based protein arginine deiminase inhibitors: synthesis, pharmacokinetics, and in cellulo efficacy.","volume":"3","author":"Bicker","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.4049\/jimmunol.1001620","article-title":"N-\u03b1-benzoylN5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.","volume":"186","author":"Willis","year":"2011","journal-title":"J Immunol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"e53791","DOI":"10.1371\/journal.pone.0053791","article-title":"The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest.","volume":"8","author":"Cui","year":"2013","journal-title":"PLoS One"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"36053","DOI":"10.18632\/oncotarget.5937","article-title":"Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.","volume":"6","author":"Witalison","year":"2015","journal-title":"Oncotarget"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"e1000632","DOI":"10.1371\/journal.pgen.1000832","article-title":"U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line.","volume":"6","author":"Clark","year":"2010","journal-title":"PLoS Genet"},{"key":"R20-20250503","first-page":"936","article-title":"Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.","volume":"47","author":"Carmicheal","year":"1987","journal-title":"Cancer Res"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0361-090X(03)00026-6","article-title":"Association of cellular apoptosis with anti-tumor effects of the Chinese herbal complex in endocrine-resistant cancer cell line.","volume":"27","author":"Lian","year":"2003","journal-title":"Cancer Detect Prev"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/17843286.2017.1302623","article-title":"The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib.","volume":"72","author":"Eng\u00fcr","year":"2017","journal-title":"Acta Clin Belg"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3923\/ijp.2016.351.360","article-title":"Effects of DNMT and HDAC inhibitors (RG108 and trichostatin a) on NGF-induced Neurite outgrowth and cellular migration.","volume":"12","author":"Kaya-Tilki","year":"2016","journal-title":"Int J Pharmacol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1007\/s11033-022-07329-w","article-title":"Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c \u2018hydrocortisone-polarised\u2019macrophages.","volume":"49","author":"Eng\u00fcr-\u00d6zt\u00fcrk","year":"2022","journal-title":"Mol Biol Rep"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neures.2006.04.005","article-title":"Mitochondrial membrane potential and ischemic neuronal death.","volume":"55","author":"Iijima","year":"2006","journal-title":"Neurosci Res"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.intimp.2006.11.013","article-title":"Nonylphenol induces apoptosis of Jurkat cells by a caspase-8 dependent mechanism.","volume":"7","author":"Yao","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/08923973.2015.1122616","article-title":"Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells.","volume":"38","author":"Eng\u00fcr","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"e57401","DOI":"10.1371\/journal.pone.0057401","article-title":"Multiple marker detection in peripheral blood for NSCLC diagnosis.","volume":"8","author":"Ulivi","year":"2013","journal-title":"PLoS One"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"188492","DOI":"10.1016\/j.bbcan.2020.188492","article-title":"PADs in cancer: current and future.","volume":"1875","author":"Zhang","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/cb200258q","article-title":"Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.","volume":"7","author":"Jones","year":"2012","journal-title":"ACS Chem Biol"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/MCB.01747-07","article-title":"Regulation of p53 target gene expression by peptidylarginine deiminase 4.","volume":"28","author":"Li","year":"2008","journal-title":"Mol Cell Biol"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41385-019-0139-3","article-title":"PAD4-dependent NETs generation are indispensable for intestinal clearance of Citrobacter rodentium.","volume":"12","author":"Saha","year":"2019","journal-title":"Mucosal Immunol"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"174623","DOI":"10.1016\/j.ejphar.2021.174623","article-title":"Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.","volume":"916","author":"Shen","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000448808","article-title":"Cl-amidine prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model.","volume":"9","author":"Biron","year":"2017","journal-title":"J Innate Immun"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"e41242","DOI":"10.1371\/journal.pone.0041242","article-title":"Potential role for PAD2 in gene regulation in breast cancer cells.","volume":"7","author":"Cherrington","year":"2012","journal-title":"PLoS One"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"25941","DOI":"10.1074\/jbc.M112.375725","article-title":"Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.","volume":"287","author":"Wang","year":"2012","journal-title":"J Biol Chem"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00018-010-0480-x","article-title":"Protein arginine deiminase 4: a target for an epigenetic cancer therapy.","volume":"68","author":"Slack","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"26192","DOI":"10.3402\/jev.v4.26192","article-title":"A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.","volume":"4","author":"Kholia","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/002215549804600804","article-title":"Comparison of Annexin V and calcein-AM as early vital markers of apoptosis in adherent cells by confocal laser microscopy.","volume":"46","author":"Gatti","year":"1998","journal-title":"J Histochem Cytochem"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V84.5.1415.bloodjournal8451415","article-title":"Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.","volume":"84","author":"Kopman","year":"1994","journal-title":"Blood"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1009649025439","article-title":"Early features of apoptosis detected by four different flow cytometry assays.","volume":"3","author":"Overbeeke","year":"1998","journal-title":"Apoptosis"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2144\/97233pf01","article-title":"Early detection of apoptosis using a fluorescent conjugate of Annexin V.","volume":"23","author":"Zhang","year":"1997","journal-title":"Biotechniques"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/molehr\/4.8.757","article-title":"Germ cell apoptosis in men with complete and incomplete spermiogenesis failure.","volume":"4","author":"Tesarik","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0304-4165(99)00073-2","article-title":"Bcl-2 protects against FCCP-induced apoptosis and mitochondrial membrane potential depolarization in PC12 cells.","volume":"1428","author":"Dispersyn","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0962-8924(01)02173-0","article-title":"Programmed cell death: alive and well in the new millennium.","volume":"11","author":"Kaufmann","year":"2001","journal-title":"Trends Cell Biol"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1074\/jbc.M008363200","article-title":"Executioner caspases-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis.","volume":"276","author":"Slee","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:30:57Z","timestamp":1746318657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037015","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}